Veracyte (VCYT), MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to Veracyte (VCYT), MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System

Veracyte (VCYT) Tops Q2 EPS by 2c

July 30, 2020 4:28 PM EDT

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $20.6 million.

Second Quarter 2020 Financial Results

For the second quarter of 2020:

Total revenue was $20.7 million, comprising $16.9 million in testing and product revenue and $3.8 million in... More